• Have any questions?
  • +040 42444222 Ext: 6612
  • info@ahcf.co.in
Contact us

Genomics & Sequencing

Introduction

The Genomics and Sequencing Lab is a state-of-the-art facility dedicated to high-throughput genomic research and molecular profiling. Equipped with advanced platforms like next-generation sequencer (NGS), Sanger’s sequencer, Microarray, and quantitative PCR, the lab supports a broad range of applications including whole exome sequencing, transcriptomics, epigenomics and targeted panel analysis.

Our mission is to enable precision research in areas such as Gastrointestinal diseases and Cancer with specific emphasis on NASH (Non-alcoholic steato hepatitis) and Colorectal Cancer. The lab is interested in understanding the genetic susceptibility underlying NASH and the dysregulated pathways involved in the tumorigenesis of Colorectal cancer. By generating high quality data and integrating robust bioinformatics pipelines the lab envisions to unravel complex biological questions and translate genomic insights into impactful outcomes benefitting patient care. In addition, the lab also supports Clinicians across various super specialities in delineating genetic susceptibility underlying the diseases of relevance

Genomics & Sequencing Lab

Dr. V.V. Ravikanth

PhD

Scientist,
Genomics & Sequencing​ Lab,
Asian Healthcare Foundation
Hyderabad

Member, Advisory Committee
DBT-Sponsored M.Sc. Teaching Programme in Molecular & Human Genetics (MHG)
Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Begumpet, Hyderabad.

Email: ravikanth@ahcf.co.in

Biography

Educated (M.Sc and PhD in Genetics) and trained in the area of Genomics and Molecular Biology. Post PhD, I worked with Vimta labs, a CRO based in Hyderabad, and was instrumental in the successful completion of large Genome wide association and expression based studies on the microarray platform (Affymetrix). Currently, as the Group Leader of Genetics and Clinical Genomics lab at Asian Healthcare Foundation (a research wing of AIG Hospitals, Gachibowli), our lab focuses on identifying genetic susceptibility majorly for gastrointestinal diseases. The lab employs both Next generation sequencing (NGS) and microarray platforms to identify genetic susceptibility for Non-alcoholic fatty liver disease and dysregulated pathways in colorectal cancer. I am instrumental in the successful completed of two funded projects (ICMR) and have 2 ongoing projects (as Principal Investigator) and 2 (as Co-Investigator) from ICMR, SERB and DBT. I have ~50 peer reviewed, national and international publications to my credit.

Research

  • Delineating genetic susceptibility underlying complex genetic diseases

Research

Overview

Research Focus Areas

Principal Investigator

Dr. V V Ravikanth

 Scientist Incharge

Team Members

Govardhan Bale

Govardhan Bale

Senior Research Fellow
Urmila Steffie Avanthi

Urmila Steffie Avanthi

Senior Research Fellow
Anil Kumar Vashapaka

Anil Kumar Vashapaka

Senior Research Fellow
Priyanka Mattela

Priyanka Mattela

Research Assistant
Sharada Gonuguntala

Sharada Gonuguntala

Research Assistant
Tanya Muthu

Tanya Muthu

Research Assistant
  • A gene panel to predict response to adjuvant chemotherapy and risk of recurrence in colorectal cancer. Steffie U. A., Ravikanth V., Mitnala S., Guduru V. R., Rebala P., Patil S. M., Sekaran A., Jain A., Mondkar S., Reddy D. N. Malignancy Spectrum. 2025; 2(2):84–94. doi:10.1002/msp2.70009
  • Clinical and genetic profile of pediatric and adult Wilson’s disease in India. Kulkarni A. V., Bale G., Vishnubhotla R., et al. Gastro Hep Advances. 2025; 4(9):100717.
  • Prevalence of metabolic dysfunction-associated fatty liver disease among information technology employees in India. Bhargava B., Rao P. N., Kulkarni A. V., Vishnubhotla R., Pramod N., Anitha C. T., Mahadev K. Scientific Reports. 2025; 15(1):10124. doi:10.1038/s41598-025-91482-2
  • Transcriptomic analysis of pancreatic tissue from humans and mice identifies potential gene signatures and unexplored pathways during progression from acute to chronic pancreatitis. Galande S., Ravikanth V. V., Tokala R. K., Satyanarayana Singh S., Rao G. V., Talukdar R., Peddapulla C., Reddy D. N., Sasikala M. Gene. 2025; 940:149200. doi:10.1016/j.gene.2024.149200
  • Upregulated expression of DDR2 and MYLK correlates with poor prognosis in colorectal tumours. Steffie U. A., Mondkar S., Venkat Rao G., Rebala P., Patil S. M., Shetty M., Sasikala M., Sekaran A., Reddy D. N., Pinnamaneni R., Vishnubhotla R. Human Gene. 2025; 43:201358.
  • Hereditary pancreatitis with a N29I mutation in the PRSS1 (Trypsinogen) gene: A case report from India. Rodrigues M., Mattela P., Talukdar R., Peddapulla C., Lakhtakia S., Sasikala M., Reddy N. R., Vishnubhotla R. Indian Journal of Gastroenterology. Published online 2025 Jan 17. doi:10.1007/s12664-024-01722-y
  • 17-Beta-hydroxysteroid dehydrogenase 13 loss of function does not confer protection to nonalcoholic fatty liver disease in Indian population. Bale G., Kulkarni A. V., Rao P. N., Menon P. B., Sharma M., Sasikala M., Sowmya T. R., Sekaran A., Pawar S. C., Reddy D. N., Vishnubhotla R. Journal of Clinical and Experimental Hepatology. 2024; 14(4):101371. doi:10.1016/j.jceh.2024.101371
  • Genetic cardiomyopathies misdiagnosed as cardiac sarcoidosis. Subramanian M., Ravikanth V., Saggu D., Yalagudri S., Narasimhan C. JACC: Clinical Electrophysiology. 2024; 10(3):583–584.
  • Circulating tumor DNA for monitoring colorectal cancer: A prospective observational study to assess the presence of methylated SEPT9 and VIM promoter genes and its role as a biomarker in colorectal cancer management. Gopal P., Ahmed Z., Venkata Ravi Kant V., Rao G. V., Rebala P. Turkish Journal of Surgery. 2023; 39(2):107–114. doi:10.47717/turkjsurg.2023.6038
  • Next generation sequencing-based detection of bacterial species in bile after liver transplantation: Hope, hype or hyperbole? Rao P. N., Vishnubhotla R., Talukdar R. Journal of Clinical and Experimental Hepatology. 2024; 14(1):101311. doi:10.1016/j.jceh.2023.101311
  • Lesser prevalence of polyps/WNT dysregulation and concomitant upregulation of γ-catenin/MYC point to alternate pathways in colorectal cancer in India. Vishnubhotla R., Avanthi S., Mitnala S., Guduru V. R., Rebala P., Patil S. M., Shetty M., Sekaran A., Duvvur N. R. Molecular Carcinogenesis. 2024; 63(3):361–370. PMID:37983720.
  • Comparing rare variants versus common in the pathogenesis of nonalcoholic fatty liver disease: A whole-exome sequencing approach. Bale G., Kulkarni A. V., Padaki N. R., Menon P. B., Sharma M., Iyengar S., Sekaran A., Pawar S. C., Duvvur N. R., Vishnubhotla R. Journal of Gastroenterology and Hepatology. 2023. doi:10.1111/jgh.16394
  • MicroRNAs as a therapeutic target in IgA nephropathy in the Indian population. Tripathy A., Yedla P., Vishnubhotla R. V., Sekaran A., Keithi Reddy S. R. Biomedical Reports. 2023; 18(5):35. doi:10.3892/br.2023.1617
  • Newly diagnosed Crohn’s disease patients in India and Israel display distinct presentations and serological markers: Insights from prospective cohorts. Goren I., Sharar Fischler T., Yanai H., Pal P., Adigopula B., Pendyala S., Ganesh G., Vishnubhotla R., Rabinowitz K. M., Shaham Barda E., Yadamreddy D., Godny L., Peleg N., Banerjee R., Dotan I.; on behalf of TIIIGER. Journal of Clinical Medicine. 2022; 11(23):6899. doi:10.3390/jcm11236899
  • An update on the genetics of alcoholic liver disease. Vishnubhotla R., Kulkarni A. V., Sharma M., Rao P. N., Reddy D. N. Frontiers in Gastroenterology. 2022. doi:10.3389/fgstr.2022.1030399
  • Integration of metabolites from meta-analysis with transcriptome reveals enhanced SPHK1 in PDAC with a background of pancreatitis. Ketavarapu V., Ravikanth V., Sasikala M., Rao G. V., Devi C. V., Sripadi P., Bethu M. S., Amanchy R., HVV Murthy, Pandol S. J., Reddy D. N. BMC Cancer. 2022; 22(1):792. doi:10.1186/s12885-022-09816-6
  • Structure of human TMPRSS2 in complex with SARS-CoV-2 spike glycoprotein and implications for potential therapeutics. Vankadari N., Ketavarapu V., Mitnala S., Vishnubotla R., Reddy D. N., Ghosal D. The Journal of Physical Chemistry Letters. 2022; 13(23):5324–5333. doi:10.1021/acs.jpclett.2c00967
  • I148M variant of the PNPLA3 gene is not associated with metabolic syndrome in patients with NAFLD in Indian ethnicity. Bale G., Mitnala S., Rao P. N., Sharma M., Kulkarni A. V., Pawar S. C., Reddy D. N., Vishnubhotla R. Human Gene. 2022; 29:201073. doi:10.1016/j.humgen.2022.201073
  • Effectiveness of REGEN-COV antibody cocktail against the B.1.617.2 (Delta) variant of SARS-CoV-2: A cohort study. Kumar V. J., Banu S., Sasikala M., Parsa K. V. L., Sowpati D. T., Yadav R., Tallapaka K. B., Siva A. B., Vishnubhotla R., Rao G. V., Reddy D. N. Journal of Internal Medicine. 2022; 291(3):380–383. doi:10.1111/joim.13408
  • High-resolution HLA genotyping identifies alleles associated with severe COVID-19: A preliminary study from India. Vishnubhotla R., Sasikala M., Ketavarapu V., Reddy D. N. Immunity, Inflammation and Disease. 2021; 9(4):1781–1785. doi:10.1002/iid3.481
  • A variant in TMPRSS2 is associated with decreased disease severity in COVID-19. Ravikanth V., Sasikala M., Naveen V., Latha S. S., Parsa K. V. L., Vijayasarathy K., Amanchy R., Avanthi S., Govardhan B., Rakesh K., Kumari D. S., Srikaran B., Rao G. V., Reddy D. N. Meta Gene. 2021; 29:100930. doi:10.1016/j.mgene.2021.100930
  • Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals. Sasikala M., Shashidhar J., Deepika G., Ravikanth V., Krishna V. V., Sadhana Y., Pragathi K., Reddy D. N. International Journal of Infectious Diseases. 2021; 108:183–186. doi:10.1016/j.ijid.2021.05.034
  • NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine-induced leucopenia: Prospective analysis of 1014 inflammatory bowel disease patients in India. Banerjee R., Ravikanth V. V., Pal P., et al. Alimentary Pharmacology & Therapeutics. 2020; 52(11–12):1683–1694. doi:10.1111/apt.16137
  • Pancreas divisum increases the risk of recurrent acute pancreatitis in patients with rs12338 polymorphism in the cathepsin B gene. Talukdar R., Aslam M., Reddy D. N., Nabi Z., Shava U., Ravikanth V. V., Avanthi S., Govardhan B. Digestive Diseases and Sciences. 2021; 66(7):2283–2290. doi:10.1007/s10620-020-06517-7
  • Genetic evaluation of children with idiopathic recurrent acute pancreatitis. Nabi Z., Talukdar R., Venkata R., Aslam M., Shava U., Reddy D. N. Digestive Diseases and Sciences. 2020; 65(10):3000–3005. doi:10.1007/s10620-019-06026-2
  • Next-generation sequencing (NGS) in the prediction of pancreatic malignancy: Does cell-free mean error-free? Ravikanth V. V. Digestive Diseases and Sciences. 2020; 65(8):2153–2155. doi:10.1007/s10620-020-06209-2 (Invited commentary)
  • Whole-exome sequencing identifies a variant in the PEMT gene associated with lean nonalcoholic fatty liver disease (NAFLD). Bale G., Vishnubhotla V. R. K., Mitnala S., Sharma M., Rao P. N., Pawar S. C., Reddy D. N. Journal of Clinical and Experimental Hepatology. 2019; 9(5):561–568. doi:10.1016/j.jceh.2019.02.001
  • Transcriptome profiles and gene expression of MIN6 cells are altered by pancreatic stellate cells. Bynigeri R., Mitnala S., Vishnubhotla R., Talukdar R., Singh S., Reddy D. N. Advances in Bioscience and Biotechnology. 2018; 9:273–288. doi:10.4236/abb.2018.96018
  • Incidence and risk of gallstone disease in Gilbert’s syndrome patients in the Indian population. Bale G., Avanthi U. S., Rao P. N., Sharma M., Reddy D. N., Vishnubhotla V. R. K. Journal of Clinical and Experimental Hepatology. 2018; 8(4):362–366. doi:10.1016/j.jceh.2017.12.006
  • PRSS1 (R122H) mutation in an Indian family with low penetrance is associated with a pancreatitis phenotype. Avanthi U. S., Bale G., Aslam M., Talukdar R., Duvvur N. R., Vishnubhotla R. V. Indian Journal of Gastroenterology. 2018; 37(1):67–69. doi:10.1007/s12664-018-0828-y
  • Bach2 repression mediates Th17 cell–induced inflammation and associates with clinical features of advanced disease in chronic pancreatitis. Sasikala M., Ravi Kanth V. V., Manohar K. M., Deshpande N., Singh S., Pavan Kumar P., Talukdar R., Ghosh S., Aslam M., Rao G. V., Pradeep R., Reddy D. N. United European Gastroenterology Journal. 2018; 6(2):272–282. doi:10.1177/2050640617716596 (co-first authors)
  • Regional differences in genetic susceptibility to non-alcoholic liver disease in two distinct Indian ethnicities. Bale G., Avanthi U. S., Ravi Kanth V. V., Rao P. N., Sharma M., Sasikala M., Reddy D. N. World Journal of Hepatology. 2017; 9(26):1101–1107. doi:10.4254/wjh.v9.i26.1101
  • Hereditary persistence of alpha-fetoprotein is associated with the −119G>A polymorphism in the AFP gene. Deshpande N., Chavan R., Bale G., Avanthi U. S., Aslam M., Ramchandani M., Reddy D. N., Ravikanth V. V. ACG Case Reports Journal. 2017; 4:e33. doi:10.14309/crj.2017.33
  • Polymorphisms in UGT1A1 gene predispose South Indians to pigment gallstones. Ravi Kanth V. V., Rao G. V., Govardhan B., Sasikala M., Subramanyam C., HVV Murthy, Siva Prasad S., Deepika G., Pradeep R., Reddy D. N. Journal of Clinical and Experimental Hepatology. 2016; 6(3):216–223. doi:10.1016/j.jceh.2016.08.004
  • Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to management. Ravi Kanth V. V., Sasikala M., Sharma M., Rao P. N., Reddy D. N. World Journal of Hepatology. 2016; 8(20):827–837. doi:10.4254/wjh.v8.i20.827
  • Rapid and ultra-rapid metabolizers with CYP2C19*17 polymorphism do not respond to standard therapy with proton-pump inhibitors. Deshpande N., Sharanya V., Ravi Kanth V. V., Murthy H. V. V., Sasikala M., Banerjee R., Tandan M., Reddy D. N. Meta Gene. 2016; 9:159–164. doi:10.1016/j.mgene.2016.06.004
  • Association of CLDN2 and PRSS1-PRSS2 polymorphisms with idiopathic recurrent acute and chronic pancreatitis: A case–control study from India. Avanthi S. U., Ravi Kanth V. V., Agarwal J., Lakhtakia S., Gangineni K., Rao G. V., Reddy D. N., Talukdar R. Journal of Gastroenterology and Hepatology. 2015; 30(12):1796–1801. doi:10.1111/jgh.13029
  • The riddle of nonalcoholic fatty liver disease: Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis. Sharma M., Mitnala S., Vishnubhotla R. K., Mukherjee R., Reddy D. N., Rao P. N. Journal of Clinical and Experimental Hepatology. 2015; 5(2):147–158. doi:10.1016/j.jceh.2015.02.002
  • Role of matrix metalloproteinases in physiological processes and disease. Ravi Kanth V. V., Reddy D. N. Indian Journal of Medical Research. 2014; 140:30–32. (Invited commentary)
  • Genetics of acute and chronic pancreatitis – An update. Ravi Kanth V. V., Reddy D. N. World Journal of Gastrointestinal Pathophysiology. 2014; 5(4):427–437. doi:10.4291/wjgp.v5.i4.427 (Invited review)
  • Pooled genetic analysis in ultrasound-measured NAFLD in Indian subjects: A pilot study. Ravi Kanth V. V., Sasikala M., Rao P. N., Avanthi U. S., Rajender Rao K., Reddy D. N. World Journal of Hepatology. 2014; 6(6):435–442. doi:10.4254/wjh.v6.i6.435
  • Microsatellite instability and promoter hypermethylation in colorectal cancer in India. Ravi Kanth V. V., Bhalsing S., Sasikala M., Rao G. V., Pradeep R., Avanthi U. S., Reddy D. N. Tumor Biology. 2014; 35(5):4347–4355. doi:10.1007/s13277-013-1570-9
  • Differences in gene-expression profiles between human breast tissue and peripheral blood samples for breast cancer detection. Mahesh K., Kalyana Kumar C., Ravi Kanth V. V., Addala L., Sudha M., et al. Journal of Cancer Science & Therapy. 2012; 4:379–385. doi:10.4172/1948-5956.1000171
  • Genetic interactions between MTHFR (C677T) and methionine synthase (A2756G, C2758G) variants with vitamin B12 and folic acid determine susceptibility to premature coronary artery disease in an Indian population. Ravi Kanth V. V., Prakash G. J., Sastry B. K. S., Sudhir Naik, Nitin Kabra, Sujatha M. Journal of Cardiovascular Disease Research. 2011; 2:156–163. doi:10.4103/0975-3583.85262
  • Nitric oxide as a major risk factor for oxidative stress in coronary artery disease: A preliminary investigation. Das J. S., Ravikanth V. V., Sujatha M. Science & Culture. 2010; 76(5–6):174–175.
  • Mutational analysis of the inhibin-α gene revealed three novel variations in Indian women with premature ovarian failure. Prakash G. J., Ravi Kanth V. V., Shilling A., Rozati R., Sujatha M. Fertility and Sterility. 2010; 94(1):90–98. doi:10.1016/j.fertnstert.2009.02.014
  • Absence of the 566C>T mutation in exon 7 of the FSHR gene in Indian women with premature ovarian failure. Prakash G. J., Ravi Kanth V. V., Shilling A., Rozati R., Sujatha M. International Journal of Gynecology & Obstetrics. 2009; 105(3):265–266. doi:10.1016/j.ijgo.2009.01.023
  • Premature coronary artery disease: Role of free-radical nitric oxide. Ravi Kanth V. V., Prakash G. J., Sudhir Naik, Nitin Kabra, Sujatha M. Indian Heart Journal. 2008; 60(1):45–49.

Conference Presentations & Abstracts

  • Microarray analysis of placenta-derived mesenchymal stromal cells
    Smitha Mathews, V.V. Ravi Kanth, et al. – International Congress of Cell Biology, 2018

  • Multiple gene interaction in pancreatitis with pancreas divisum
    Rupjyoti Talukdar, V.V. Ravi Kanth, et al. – Digestive Disease Week (DDW), 2017

  • Transcriptome array in chronic pancreatitis to pancreatic cancer
    V.V. Ravi Kanth, Mitnala Sasikala, et al. – DDW, 2017

  • COMT gene variant and pain in chronic pancreatitis
    V.V. Ravi Kanth, Steffie Avanthi, et al. – PancreasFest, 2016

  • Pancreas divisum and cathepsin B polymorphism
    Mohsin Aslam, Steffie Avanthi, et al. – Pancreatology, 2016

  • Alternate pathways in Indian colorectal cancer
    V. Sharanya, V.V. Ravi Kanth, et al. – DDW, 2016

  • CYP2C19*17 polymorphism and PPI therapy
    Neha Deshpande, V.V. Ravi Kanth, et al. – Indian Society of Gastroenterology (ISG Annual Conference), 2015

  • Genetics of pancreatitis in children
    Zaheer Nabi, V.V. Ravi Kanth, et al. – ISG Annual Conference, 2015

  • CYP2C19 polymorphisms impact on esomeprazole pharmacokinetics
    V. Sharanya, V.V. Ravi Kanth, et al. – Society for Biological Chemists, India (SBCI), 2014

  • Claudin-2 polymorphism and Indian pancreatitis
    J. Agarwal, V.V. Ravi Kanth, et al. – Asian Pacific Digestive Disease Week (IDDF), 2014

  • CFTR mutations in Indian chronic pancreatitis
    Steffie Avanthi, V.V. Ravi Kanth, et al. – ISG Annual Conference, 2013

  • PNPLA3 polymorphism and NAFLD severity
    Steffie Avanthi, V.V. Ravi Kanth, et al. – Indian National Association for Study of the Liver (INASL), 2013

  • PNPLA3 gene polymorphism but not APOC3 in NAFLD
    V.V. Ravi Kanth, Steffie Avanthi, et al. – INASL, 2013

Plenary & Oral Presentations

  • PTGIS and LYVE1 expression predicts chemotherapy response
    V.V. Ravi Kanth, Steffie U.A., et al. – ISG Annual Conference, 2017

  • CYP2C19*17 and proton pump inhibitor resistance
    Neha Deshpande, V.V. Ravi Kanth, et al. – International Conference on Biological and Natural Products (ICBNP), Osmania University, 2015

  • Microsatellite instability and hypermethylation in colorectal cancer
    V.V. Ravi Kanth, Steffie Avanthi, et al. – ISG Annual Conference, 2013

 Book Chapters & Reviews

  • Biomedical Aspects of Solid Cancers (Esophageal Cancer)
    Korikani M, Akula V, Vishnubhotla R, Kancha R.K. – Springer, Singapore, 2024

  • Biomedical Aspects of Solid Cancers (Stomach Cancer)
    Korikani M, Quadri M.Q.K., Vishnubhotla R, et al. – Springer, Singapore, 2024

  • Biomedical Aspects of Solid Cancers (Colorectal Cancer)
    Korikani M, Bodiga V.L., Vishnubhotla R, Kancha R.K. – Springer, Singapore, 2024

  • Biomedical Aspects of Solid Cancers (Liver Cancer)
    Annamaraju S.S., Mullaguri S.C., Putta S, Vishnubhotla R, Kancha R.K. – Springer, Singapore, 2024

  • Biomedical Aspects of Solid Cancers (Pancreatic Cancer)
    Annamaraju S.S., Mullaguri S.C., Putta S, Vishnubhotla R, Kancha R.K. – Springer, Singapore, 2024

  • Biomedical Aspects of Solid Cancers (Biliary Tract Cancers)
    Annamaraju S.S., Mullaguri S.C., Vishnubhotla R, Kancha R.K. – Springer, Singapore, 2024

  • IBD Triggers: Genetics
    V.V. Ravi Kanth – In: IBD Manual (Banerjee R, et al. eds.), 2024

International

  • PancreasFest 2016 Travel Award – Visit to University of Pittsburgh, USA
    Awarded by: CAPER (Collaborative Alliance for Pancreatic Education and Research, USA)

  • International Science Partnership Fund Travel Grant – Visit to University of Edinburgh, Scotland
    Awarded by: Scottish Funding Council

National

  • Winmedicare Award for Best Research in Gastroenterology – 2013
    Awarded by: Indian Society of Gastroenterology

  • Winmedicare Award for Best Research in Gastroenterology – 2017
    Awarded by: Indian Society of Gastroenterology

Public Dataset

  • Transcriptome Dataset in Chronic Pancreatitis and Pancreatic Cancer
    Vishnubhotla, Ravikanth (2021), Mendeley Data, V1.
    DOI: 10.17632/2jjbpvfm72.1

dbSNP Submissions – Bach2 Gene

  • ss1054349512 → rs149586909
    NC_000006.11:g.90660289G>A, Allele: A/G, Sample size: 120, Chromosome 6, Position: 89950570, Contig: NT_025741.16, Contig Position: 29720636

  • ss1054349511 → rs9451298
    NC_000006.11:g.90660319T>C, Allele: C/T, Sample size: 120, Chromosome 6, Position: 89950600, Contig: NT_025741.16, Contig Position: 29720666

  • ss1054349509 → rs45483891
    NC_000006.11:g.90916262T>G, Allele: G/T, Sample size: 120, Chromosome 6, Position: 90206543, Contig: NT_025741.16, Contig Position: 29976609

  • ss1054349508 → rs72928026
    NC_000006.11:g.90962105G>A, Allele: A/G, Sample size: 120, Chromosome 6, Position: 90252386, Contig: NT_025741.16, Contig Position: 30022452

  • ss1225254430 → rs9111
    NC_000006.11:g.90981653C>T, Allele: C/T, Sample size: 120, Chromosome 6, Position: 90271934, Contig: NT_025741.16, Contig Position: 30042000

  • ss1054349507 → rs1504215
    NC_000006.11:g.91006227G>A, Allele: A/G, Sample size: 120, Chromosome 6, Position: 90296508, Contig: NT_025741.16, Contig Position: 30066574

  • ss1054349506 → rs778535838
    NC_000006.11:g.91006595A>C, Allele: A/C, Sample size: 120, Chromosome 6, Position: 90296876, Contig: NT_025741.16, Contig Position: 30066942

Quick Links

Facilities

Contact Info

  • Asian Healthcare Foundation, Tower B, 5th & 6th Floors, AIG Hospitals, Gachibowli, Hyderabad – 500032, India
  • +040 42444222 Ext: 6612
  • info@ahcf.co.in

Copyright © 2025 AHF

Powered by dyotatech.ai